Cancer BiologybioRxiv
Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multi-kinase inhibition
J. D. Lang, W. P. D. Hendricks, H. Yin…·J. M. Trent
This paper identifies ponatinib as a potent treatment for SCCOHT by inhibiting multiple kinases in preclinical models.
DOI 10.1158/1078-0432.ccr-17-1928